Furthermore, treatment of cultured skin melanocytes with exogenous Activin-A in amounts exceeding the secreted antagonist follistatin (FST) led to cell cycle arrest, raising the possibility that activin signaling in these cells may have a tumor-suppressive function8. The gene discussed is INHBE; the disease is neoplasm.